Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Uterine Cervical Neoplasms | 55 | 2012 | 2047 | 4.830 |
Why?
|
Papillomavirus Vaccines | 27 | 2012 | 496 | 4.380 |
Why?
|
Papillomavirus Infections | 37 | 2011 | 1640 | 3.590 |
Why?
|
Cost-Benefit Analysis | 103 | 2017 | 5526 | 2.480 |
Why?
|
Human papillomavirus 16 | 15 | 2011 | 268 | 2.380 |
Why?
|
Human papillomavirus 18 | 14 | 2011 | 125 | 2.310 |
Why?
|
Mass Screening | 43 | 2015 | 5446 | 2.290 |
Why?
|
Maternal Mortality | 5 | 2023 | 313 | 2.180 |
Why?
|
Uterine Cervical Dysplasia | 12 | 2010 | 392 | 1.600 |
Why?
|
Vaccination | 16 | 2017 | 3426 | 1.470 |
Why?
|
Papillomaviridae | 15 | 2006 | 1141 | 1.470 |
Why?
|
Quality-Adjusted Life Years | 39 | 2017 | 1737 | 1.360 |
Why?
|
Markov Chains | 21 | 2010 | 968 | 1.280 |
Why?
|
Tumor Virus Infections | 7 | 2004 | 440 | 1.070 |
Why?
|
Alphapapillomavirus | 5 | 2011 | 219 | 1.060 |
Why?
|
AIDS-Related Opportunistic Infections | 15 | 2007 | 664 | 1.010 |
Why?
|
Health Care Costs | 21 | 2012 | 3242 | 0.970 |
Why?
|
Health Policy | 13 | 2024 | 2698 | 0.960 |
Why?
|
Helicobacter Infections | 5 | 2015 | 390 | 0.960 |
Why?
|
Stomach Neoplasms | 6 | 2015 | 1471 | 0.940 |
Why?
|
Helicobacter pylori | 5 | 2015 | 380 | 0.910 |
Why?
|
Developing Countries | 11 | 2017 | 2911 | 0.910 |
Why?
|
Models, Theoretical | 22 | 2013 | 3564 | 0.870 |
Why?
|
Vaginal Smears | 11 | 2011 | 513 | 0.870 |
Why?
|
Rotavirus Vaccines | 4 | 2011 | 62 | 0.830 |
Why?
|
Rotavirus Infections | 4 | 2011 | 85 | 0.820 |
Why?
|
Immunization Programs | 8 | 2017 | 267 | 0.800 |
Why?
|
DNA, Viral | 14 | 2011 | 2199 | 0.750 |
Why?
|
Models, Economic | 10 | 2010 | 716 | 0.690 |
Why?
|
Models, Econometric | 10 | 2010 | 213 | 0.610 |
Why?
|
Decision Support Techniques | 10 | 2016 | 2003 | 0.590 |
Why?
|
Anus Neoplasms | 5 | 2008 | 336 | 0.540 |
Why?
|
Computer Simulation | 20 | 2023 | 6255 | 0.540 |
Why?
|
Cost of Illness | 8 | 2017 | 1950 | 0.520 |
Why?
|
Colposcopy | 8 | 2008 | 151 | 0.510 |
Why?
|
Early Detection of Cancer | 6 | 2012 | 3236 | 0.500 |
Why?
|
Pepsinogen A | 1 | 2015 | 14 | 0.490 |
Why?
|
HIV Infections | 32 | 2011 | 17533 | 0.470 |
Why?
|
Sexually Transmitted Diseases, Viral | 2 | 2004 | 39 | 0.450 |
Why?
|
Chlamydia trachomatis | 2 | 2006 | 240 | 0.440 |
Why?
|
Abortion, Induced | 2 | 2010 | 471 | 0.430 |
Why?
|
Life Expectancy | 19 | 2011 | 1247 | 0.430 |
Why?
|
Gastroscopy | 1 | 2015 | 213 | 0.430 |
Why?
|
Delivery of Health Care | 7 | 2023 | 5370 | 0.420 |
Why?
|
Female | 112 | 2023 | 396112 | 0.400 |
Why?
|
Hepatitis C, Chronic | 3 | 2007 | 1032 | 0.390 |
Why?
|
Chlamydia Infections | 2 | 2006 | 364 | 0.390 |
Why?
|
Herpes Genitalis | 2 | 2003 | 148 | 0.370 |
Why?
|
Adenocarcinoma | 4 | 2015 | 6364 | 0.370 |
Why?
|
Humans | 167 | 2024 | 765968 | 0.370 |
Why?
|
Adult | 78 | 2015 | 223044 | 0.360 |
Why?
|
Precancerous Conditions | 3 | 2010 | 976 | 0.350 |
Why?
|
Anti-HIV Agents | 14 | 2011 | 4559 | 0.330 |
Why?
|
Office Visits | 2 | 2006 | 595 | 0.330 |
Why?
|
Guideline Adherence | 2 | 2011 | 2243 | 0.330 |
Why?
|
Empirical Research | 1 | 2010 | 119 | 0.330 |
Why?
|
Hepatitis C | 3 | 2004 | 1597 | 0.320 |
Why?
|
CD4 Lymphocyte Count | 19 | 2010 | 2587 | 0.320 |
Why?
|
Antiretroviral Therapy, Highly Active | 10 | 2010 | 1899 | 0.320 |
Why?
|
Maternal Health Services | 3 | 2012 | 472 | 0.310 |
Why?
|
Program Evaluation | 4 | 2012 | 2499 | 0.310 |
Why?
|
Syphilis, Congenital | 1 | 2008 | 26 | 0.310 |
Why?
|
Anti-Infective Agents | 3 | 2006 | 986 | 0.310 |
Why?
|
Cholera Vaccines | 1 | 2011 | 264 | 0.310 |
Why?
|
Viral Vaccines | 2 | 2004 | 597 | 0.300 |
Why?
|
Diagnostic Tests, Routine | 3 | 2004 | 790 | 0.300 |
Why?
|
Disease Outbreaks | 2 | 2011 | 1759 | 0.300 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2008 | 216 | 0.290 |
Why?
|
Models, Statistical | 7 | 2016 | 5089 | 0.290 |
Why?
|
United States | 45 | 2015 | 72903 | 0.280 |
Why?
|
Sensitivity and Specificity | 22 | 2010 | 14652 | 0.280 |
Why?
|
Pelvic Inflammatory Disease | 2 | 2006 | 95 | 0.270 |
Why?
|
Pneumococcal Vaccines | 1 | 2010 | 414 | 0.270 |
Why?
|
Hepatitis B Vaccines | 1 | 2007 | 178 | 0.260 |
Why?
|
Antiviral Agents | 6 | 2007 | 3050 | 0.260 |
Why?
|
Uncertainty | 3 | 2023 | 761 | 0.260 |
Why?
|
Forecasting | 4 | 2023 | 2936 | 0.260 |
Why?
|
Health Services Administration | 1 | 2006 | 63 | 0.250 |
Why?
|
Pneumococcal Infections | 1 | 2010 | 527 | 0.250 |
Why?
|
Models, Biological | 11 | 2010 | 9443 | 0.250 |
Why?
|
Monte Carlo Method | 6 | 2017 | 1238 | 0.250 |
Why?
|
Ribavirin | 2 | 2007 | 395 | 0.250 |
Why?
|
Interferon-alpha | 3 | 2007 | 910 | 0.250 |
Why?
|
Adolescent | 28 | 2012 | 88835 | 0.240 |
Why?
|
Developed Countries | 1 | 2008 | 452 | 0.240 |
Why?
|
Cholera | 1 | 2011 | 754 | 0.240 |
Why?
|
Primary Prevention | 3 | 2016 | 1187 | 0.240 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 368 | 0.240 |
Why?
|
Calibration | 4 | 2009 | 814 | 0.230 |
Why?
|
Herpesvirus 2, Human | 2 | 2003 | 191 | 0.230 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2012 | 953 | 0.230 |
Why?
|
Middle Aged | 46 | 2015 | 223009 | 0.220 |
Why?
|
Health Resources | 2 | 2006 | 949 | 0.210 |
Why?
|
Mortality | 3 | 2023 | 2904 | 0.210 |
Why?
|
Genital Neoplasms, Female | 1 | 2008 | 533 | 0.210 |
Why?
|
Drug Costs | 8 | 2010 | 1193 | 0.210 |
Why?
|
Family Planning Services | 3 | 2012 | 278 | 0.210 |
Why?
|
Pneumonia, Pneumocystis | 2 | 2002 | 239 | 0.210 |
Why?
|
Anti-Retroviral Agents | 3 | 2008 | 1787 | 0.200 |
Why?
|
Smoking | 4 | 2016 | 9081 | 0.200 |
Why?
|
DNA Probes, HPV | 3 | 2008 | 21 | 0.200 |
Why?
|
Pentamidine | 1 | 2002 | 44 | 0.200 |
Why?
|
Practice Guidelines as Topic | 4 | 2011 | 7425 | 0.200 |
Why?
|
Dapsone | 1 | 2002 | 57 | 0.200 |
Why?
|
Naphthoquinones | 1 | 2002 | 61 | 0.190 |
Why?
|
Therapeutics | 1 | 2002 | 113 | 0.190 |
Why?
|
Hepatitis B | 1 | 2007 | 707 | 0.190 |
Why?
|
Oncogene Proteins, Viral | 1 | 2003 | 341 | 0.190 |
Why?
|
Antiprotozoal Agents | 1 | 2002 | 93 | 0.190 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2006 | 4044 | 0.190 |
Why?
|
HIV | 4 | 2010 | 1585 | 0.190 |
Why?
|
Prenatal Diagnosis | 1 | 2008 | 1268 | 0.180 |
Why?
|
Disease Progression | 14 | 2010 | 13632 | 0.180 |
Why?
|
HIV Seropositivity | 2 | 2006 | 961 | 0.180 |
Why?
|
Bisexuality | 2 | 2000 | 295 | 0.180 |
Why?
|
Mass Media | 1 | 2004 | 301 | 0.180 |
Why?
|
Time Management | 1 | 2001 | 53 | 0.180 |
Why?
|
Gonorrhea | 1 | 2005 | 354 | 0.180 |
Why?
|
Health Education | 3 | 2004 | 1060 | 0.180 |
Why?
|
Pregnancy Outcome | 3 | 2011 | 2966 | 0.180 |
Why?
|
Incidence | 12 | 2015 | 21480 | 0.170 |
Why?
|
Women's Health Services | 1 | 2001 | 87 | 0.170 |
Why?
|
Pregnancy | 14 | 2012 | 30260 | 0.170 |
Why?
|
Endoscopy | 1 | 2010 | 1841 | 0.170 |
Why?
|
China | 4 | 2010 | 2385 | 0.170 |
Why?
|
Dilatation and Curettage | 2 | 2010 | 53 | 0.170 |
Why?
|
Asia | 3 | 2011 | 628 | 0.170 |
Why?
|
Vacuum Curettage | 2 | 2010 | 44 | 0.170 |
Why?
|
Health Status Disparities | 1 | 2011 | 1880 | 0.160 |
Why?
|
Pregnancy Complications, Infectious | 4 | 2011 | 2187 | 0.160 |
Why?
|
Point-of-Care Systems | 1 | 2008 | 1217 | 0.160 |
Why?
|
Risk Factors | 23 | 2016 | 74840 | 0.160 |
Why?
|
Gambia | 2 | 2010 | 104 | 0.160 |
Why?
|
Abortifacient Agents, Nonsteroidal | 2 | 2010 | 65 | 0.160 |
Why?
|
HIV Seronegativity | 1 | 2000 | 209 | 0.160 |
Why?
|
Policy | 1 | 2023 | 511 | 0.160 |
Why?
|
Choice Behavior | 2 | 2002 | 844 | 0.160 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2004 | 618 | 0.160 |
Why?
|
Brazil | 3 | 2007 | 1248 | 0.160 |
Why?
|
Child | 19 | 2012 | 80564 | 0.160 |
Why?
|
Sexually Transmitted Diseases | 2 | 2005 | 667 | 0.150 |
Why?
|
Communicable Disease Control | 2 | 2017 | 856 | 0.150 |
Why?
|
Misoprostol | 2 | 2010 | 94 | 0.150 |
Why?
|
Drug Resistance, Viral | 4 | 2007 | 866 | 0.150 |
Why?
|
Nigeria | 2 | 2012 | 782 | 0.150 |
Why?
|
RNA, Viral | 8 | 2006 | 2864 | 0.150 |
Why?
|
Pharyngeal Neoplasms | 2 | 2008 | 113 | 0.150 |
Why?
|
Risk Reduction Behavior | 2 | 2016 | 1123 | 0.150 |
Why?
|
Cesarean Section | 2 | 2004 | 1431 | 0.150 |
Why?
|
Mexico | 3 | 2010 | 777 | 0.140 |
Why?
|
Polyethylene Glycols | 1 | 2003 | 1188 | 0.140 |
Why?
|
Direct Service Costs | 4 | 2006 | 61 | 0.140 |
Why?
|
Neoplasms | 5 | 2011 | 22340 | 0.140 |
Why?
|
Patient Compliance | 2 | 2006 | 2692 | 0.140 |
Why?
|
Stochastic Processes | 2 | 2008 | 358 | 0.140 |
Why?
|
Mass Vaccination | 2 | 2008 | 111 | 0.140 |
Why?
|
Public Health | 5 | 2015 | 2680 | 0.140 |
Why?
|
Decision Trees | 3 | 2009 | 509 | 0.140 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 605 | 0.130 |
Why?
|
Physical Examination | 1 | 2002 | 1266 | 0.130 |
Why?
|
Cytodiagnosis | 2 | 2004 | 453 | 0.130 |
Why?
|
South Africa | 4 | 2009 | 1867 | 0.130 |
Why?
|
Male | 44 | 2015 | 363698 | 0.130 |
Why?
|
Streptococcal Infections | 1 | 2001 | 617 | 0.130 |
Why?
|
Age Factors | 9 | 2009 | 18380 | 0.130 |
Why?
|
West Nile Fever | 2 | 2006 | 77 | 0.130 |
Why?
|
Healthcare Disparities | 1 | 2011 | 3413 | 0.130 |
Why?
|
Health Services Research | 3 | 2011 | 1808 | 0.120 |
Why?
|
Pregnancy Trimester, First | 2 | 2010 | 919 | 0.120 |
Why?
|
Overweight | 1 | 2006 | 2444 | 0.120 |
Why?
|
Weight Loss | 1 | 2006 | 2710 | 0.120 |
Why?
|
Yoga | 2 | 2016 | 277 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2004 | 2334 | 0.110 |
Why?
|
Time Factors | 11 | 2013 | 40065 | 0.110 |
Why?
|
Caribbean Region | 3 | 2008 | 193 | 0.110 |
Why?
|
Vietnam | 3 | 2010 | 411 | 0.110 |
Why?
|
Cholesterol | 1 | 2002 | 2898 | 0.110 |
Why?
|
Age Distribution | 4 | 2009 | 2858 | 0.110 |
Why?
|
Risk | 4 | 2009 | 9591 | 0.110 |
Why?
|
Staphylococcal Infections | 3 | 2001 | 1393 | 0.110 |
Why?
|
Pregnancy Complications | 1 | 2007 | 2975 | 0.110 |
Why?
|
Mouth Neoplasms | 2 | 2008 | 594 | 0.100 |
Why?
|
Latin America | 3 | 2008 | 416 | 0.100 |
Why?
|
Cote d'Ivoire | 3 | 2007 | 65 | 0.100 |
Why?
|
Preventive Medicine | 2 | 2007 | 246 | 0.100 |
Why?
|
India | 2 | 2010 | 2334 | 0.100 |
Why?
|
Family Planning Policy | 1 | 2012 | 7 | 0.100 |
Why?
|
Afghanistan | 1 | 2012 | 78 | 0.100 |
Why?
|
Quality of Life | 8 | 2008 | 13462 | 0.100 |
Why?
|
Pacific Islands | 2 | 2008 | 52 | 0.100 |
Why?
|
Homosexuality, Male | 1 | 2000 | 1342 | 0.100 |
Why?
|
Health Expenditures | 4 | 2018 | 2387 | 0.100 |
Why?
|
Africa, Eastern | 1 | 2011 | 76 | 0.090 |
Why?
|
Young Adult | 9 | 2013 | 59889 | 0.090 |
Why?
|
Infant | 7 | 2011 | 36386 | 0.090 |
Why?
|
Zimbabwe | 1 | 2011 | 135 | 0.090 |
Why?
|
Immunity, Herd | 1 | 2011 | 48 | 0.090 |
Why?
|
Cohort Studies | 13 | 2010 | 41649 | 0.090 |
Why?
|
Aged | 21 | 2014 | 171117 | 0.090 |
Why?
|
Costs and Cost Analysis | 3 | 2008 | 1668 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 4 | 2010 | 2203 | 0.090 |
Why?
|
Health Services Accessibility | 5 | 2012 | 5508 | 0.090 |
Why?
|
France | 4 | 2005 | 495 | 0.090 |
Why?
|
Recombinant Proteins | 3 | 2007 | 6493 | 0.090 |
Why?
|
Financial Support | 1 | 2011 | 116 | 0.090 |
Why?
|
Air Bags | 3 | 2001 | 12 | 0.090 |
Why?
|
International Agencies | 1 | 2011 | 240 | 0.090 |
Why?
|
Ganciclovir | 3 | 2001 | 257 | 0.090 |
Why?
|
Teratogens | 1 | 2011 | 121 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2001 | 1416 | 0.090 |
Why?
|
Insurance Claim Reporting | 1 | 2011 | 166 | 0.090 |
Why?
|
Population Surveillance | 3 | 2010 | 2590 | 0.080 |
Why?
|
Risk Assessment | 7 | 2016 | 24282 | 0.080 |
Why?
|
Patient Satisfaction | 1 | 2002 | 3475 | 0.080 |
Why?
|
Marketing of Health Services | 1 | 2011 | 151 | 0.080 |
Why?
|
Directly Observed Therapy | 1 | 2010 | 139 | 0.080 |
Why?
|
Peru | 1 | 2012 | 887 | 0.080 |
Why?
|
Decision Making, Organizational | 2 | 2008 | 136 | 0.080 |
Why?
|
Prevalence | 5 | 2008 | 15842 | 0.080 |
Why?
|
Rotavirus | 1 | 2010 | 110 | 0.080 |
Why?
|
Emergency Service, Hospital | 2 | 2007 | 7875 | 0.080 |
Why?
|
Benzoxazines | 1 | 2011 | 320 | 0.080 |
Why?
|
Intensive Care, Neonatal | 1 | 2010 | 200 | 0.080 |
Why?
|
Ghana | 1 | 2010 | 333 | 0.080 |
Why?
|
Health Services Misuse | 1 | 2011 | 245 | 0.080 |
Why?
|
Africa | 1 | 2011 | 725 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2017 | 874 | 0.080 |
Why?
|
Vaccines, Conjugate | 1 | 2010 | 334 | 0.080 |
Why?
|
Reagent Strips | 1 | 2008 | 40 | 0.080 |
Why?
|
Human papillomavirus 11 | 1 | 2008 | 14 | 0.080 |
Why?
|
Human papillomavirus 6 | 1 | 2008 | 16 | 0.080 |
Why?
|
Condylomata Acuminata | 1 | 2008 | 79 | 0.080 |
Why?
|
Genetic Testing | 1 | 2001 | 3595 | 0.070 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2008 | 56 | 0.070 |
Why?
|
Drug Therapy, Combination | 6 | 2006 | 6309 | 0.070 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2010 | 1354 | 0.070 |
Why?
|
Warts | 1 | 2008 | 66 | 0.070 |
Why?
|
Abnormalities, Drug-Induced | 1 | 2011 | 335 | 0.070 |
Why?
|
Cytomegalovirus Infections | 3 | 2001 | 836 | 0.070 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 151 | 0.070 |
Why?
|
Endometrial Neoplasms | 2 | 2007 | 1378 | 0.070 |
Why?
|
Vaccines, Attenuated | 1 | 2009 | 312 | 0.070 |
Why?
|
Aged, 80 and over | 7 | 2013 | 59489 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2008 | 104 | 0.070 |
Why?
|
Pregnancy Trimester, Third | 1 | 2010 | 587 | 0.070 |
Why?
|
Papilloma | 1 | 2008 | 141 | 0.070 |
Why?
|
Colombia | 1 | 2008 | 287 | 0.070 |
Why?
|
Virology | 2 | 2005 | 77 | 0.070 |
Why?
|
Patient Selection | 3 | 2016 | 4255 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2014 | 65188 | 0.070 |
Why?
|
Microbial Sensitivity Tests | 2 | 2005 | 1971 | 0.070 |
Why?
|
Health Status | 3 | 2014 | 4080 | 0.070 |
Why?
|
Health Status Indicators | 2 | 2002 | 966 | 0.070 |
Why?
|
Penile Neoplasms | 1 | 2008 | 156 | 0.070 |
Why?
|
Public Policy | 1 | 2010 | 551 | 0.060 |
Why?
|
False Positive Reactions | 1 | 2008 | 955 | 0.060 |
Why?
|
West Nile virus | 1 | 2006 | 77 | 0.060 |
Why?
|
Decision Making | 5 | 2008 | 3965 | 0.060 |
Why?
|
Life Style | 2 | 2016 | 3926 | 0.060 |
Why?
|
Budgets | 2 | 2005 | 232 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2013 | 1741 | 0.060 |
Why?
|
Health Care Rationing | 3 | 2007 | 436 | 0.060 |
Why?
|
Africa South of the Sahara | 1 | 2008 | 751 | 0.060 |
Why?
|
Vulvar Neoplasms | 1 | 2008 | 270 | 0.060 |
Why?
|
Penicillins | 1 | 2008 | 404 | 0.060 |
Why?
|
Carcinoma | 2 | 2009 | 2312 | 0.060 |
Why?
|
Smoking Cessation | 2 | 2016 | 2084 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2011 | 21056 | 0.060 |
Why?
|
Atrioventricular Node | 1 | 2006 | 180 | 0.060 |
Why?
|
Sentinel Surveillance | 1 | 2007 | 293 | 0.060 |
Why?
|
Adolescent Health Services | 1 | 2007 | 217 | 0.060 |
Why?
|
National Health Programs | 1 | 2008 | 443 | 0.060 |
Why?
|
HIV Fusion Inhibitors | 1 | 2005 | 82 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2007 | 287 | 0.060 |
Why?
|
Immunotherapy, Active | 1 | 2004 | 58 | 0.060 |
Why?
|
Urban Health | 1 | 2007 | 530 | 0.060 |
Why?
|
Child, Preschool | 5 | 2011 | 42500 | 0.060 |
Why?
|
Actuarial Analysis | 1 | 2004 | 366 | 0.060 |
Why?
|
Triage | 2 | 2008 | 996 | 0.060 |
Why?
|
Hong Kong | 1 | 2004 | 169 | 0.060 |
Why?
|
Rape | 1 | 2005 | 131 | 0.060 |
Why?
|
Heart Block | 1 | 2006 | 391 | 0.060 |
Why?
|
Referral and Consultation | 2 | 2008 | 3615 | 0.060 |
Why?
|
Evidence-Based Practice | 1 | 2008 | 500 | 0.050 |
Why?
|
Obesity | 1 | 2006 | 13076 | 0.050 |
Why?
|
Cancer Vaccines | 1 | 2011 | 1044 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2008 | 1326 | 0.050 |
Why?
|
Germany | 1 | 2006 | 882 | 0.050 |
Why?
|
HIV-1 | 5 | 2007 | 6944 | 0.050 |
Why?
|
Chemoprevention | 2 | 2002 | 327 | 0.050 |
Why?
|
HIV Envelope Protein gp41 | 1 | 2005 | 306 | 0.050 |
Why?
|
Preventive Health Services | 2 | 2015 | 570 | 0.050 |
Why?
|
Italy | 1 | 2005 | 854 | 0.050 |
Why?
|
Infant, Newborn | 5 | 2010 | 26346 | 0.050 |
Why?
|
Acetic Acid | 1 | 2002 | 58 | 0.050 |
Why?
|
Income | 2 | 2002 | 1874 | 0.050 |
Why?
|
Diet, Reducing | 1 | 2006 | 487 | 0.050 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2005 | 335 | 0.050 |
Why?
|
Anti-Obesity Agents | 1 | 2006 | 242 | 0.050 |
Why?
|
Neisseria gonorrhoeae | 1 | 2005 | 248 | 0.050 |
Why?
|
Social Class | 1 | 2011 | 2007 | 0.050 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2008 | 492 | 0.050 |
Why?
|
Atovaquone | 1 | 2002 | 56 | 0.050 |
Why?
|
Body Constitution | 1 | 2002 | 272 | 0.050 |
Why?
|
Disease-Free Survival | 2 | 2003 | 6832 | 0.050 |
Why?
|
Resource Allocation | 1 | 2004 | 354 | 0.050 |
Why?
|
Massachusetts | 3 | 2011 | 8875 | 0.050 |
Why?
|
Primary Health Care | 1 | 2018 | 4736 | 0.050 |
Why?
|
Genotype | 3 | 2007 | 13024 | 0.050 |
Why?
|
Pregnancy, Ectopic | 1 | 2003 | 146 | 0.050 |
Why?
|
Infant Equipment | 1 | 2001 | 23 | 0.050 |
Why?
|
Medical Assistance | 1 | 2002 | 109 | 0.050 |
Why?
|
Cause of Death | 3 | 2010 | 3708 | 0.050 |
Why?
|
Social Values | 1 | 2002 | 224 | 0.050 |
Why?
|
Fibrosis | 1 | 2008 | 2070 | 0.050 |
Why?
|
Cost Allocation | 1 | 2001 | 47 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2002 | 404 | 0.050 |
Why?
|
Rural Health Services | 1 | 2005 | 393 | 0.050 |
Why?
|
Television | 1 | 2004 | 409 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2007 | 14751 | 0.040 |
Why?
|
Condoms | 1 | 2003 | 336 | 0.040 |
Why?
|
Value of Life | 1 | 2001 | 97 | 0.040 |
Why?
|
Automobiles | 1 | 2001 | 103 | 0.040 |
Why?
|
Heterosexuality | 1 | 2003 | 308 | 0.040 |
Why?
|
Vancomycin | 2 | 2001 | 504 | 0.040 |
Why?
|
Pelvic Pain | 1 | 2003 | 300 | 0.040 |
Why?
|
Netherlands | 1 | 2005 | 2277 | 0.040 |
Why?
|
DNA, Bacterial | 1 | 2005 | 1477 | 0.040 |
Why?
|
Delivery, Obstetric | 1 | 2007 | 946 | 0.040 |
Why?
|
State Health Plans | 1 | 2002 | 220 | 0.040 |
Why?
|
Women, Working | 1 | 2001 | 85 | 0.040 |
Why?
|
Cardiovascular Diseases | 3 | 2016 | 15652 | 0.040 |
Why?
|
Pacemaker, Artificial | 1 | 2006 | 827 | 0.040 |
Why?
|
Insurance, Pharmaceutical Services | 1 | 2002 | 347 | 0.040 |
Why?
|
Cardiovascular Agents | 1 | 2006 | 851 | 0.040 |
Why?
|
Survivors | 1 | 2010 | 2372 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2002 | 677 | 0.040 |
Why?
|
Policy Making | 1 | 2002 | 546 | 0.040 |
Why?
|
Survival Analysis | 3 | 2007 | 10070 | 0.040 |
Why?
|
Healthy People Programs | 1 | 2018 | 54 | 0.040 |
Why?
|
Salaries and Fringe Benefits | 1 | 2001 | 258 | 0.040 |
Why?
|
Homosexuality | 1 | 1999 | 267 | 0.040 |
Why?
|
Viral Load | 2 | 2010 | 3386 | 0.040 |
Why?
|
Educational Status | 2 | 2003 | 2513 | 0.040 |
Why?
|
AIDS Vaccines | 1 | 2004 | 898 | 0.040 |
Why?
|
Debridement | 1 | 2001 | 495 | 0.040 |
Why?
|
International Cooperation | 2 | 2015 | 1432 | 0.040 |
Why?
|
Logistic Models | 2 | 2011 | 13266 | 0.040 |
Why?
|
Mammography | 1 | 2008 | 2423 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2002 | 4850 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2014 | 10383 | 0.040 |
Why?
|
Public Health Practice | 1 | 2000 | 219 | 0.040 |
Why?
|
Posture | 1 | 2001 | 954 | 0.030 |
Why?
|
Infertility, Female | 1 | 2003 | 763 | 0.030 |
Why?
|
Medical Oncology | 1 | 2009 | 2339 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 2001 | 444 | 0.030 |
Why?
|
Peritoneal Dialysis, Continuous Ambulatory | 1 | 1996 | 29 | 0.030 |
Why?
|
Safety | 1 | 2001 | 1157 | 0.030 |
Why?
|
Cytomegalovirus | 2 | 2001 | 751 | 0.030 |
Why?
|
Antibiotic Prophylaxis | 1 | 2001 | 644 | 0.030 |
Why?
|
Defibrillators, Implantable | 1 | 2006 | 1490 | 0.030 |
Why?
|
Biopsy | 1 | 2008 | 6763 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2001 | 838 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2007 | 11206 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2008 | 2329 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 2001 | 818 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2003 | 1275 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3807 | 0.030 |
Why?
|
Urban Population | 1 | 2003 | 2040 | 0.030 |
Why?
|
Sex Factors | 1 | 2009 | 10603 | 0.030 |
Why?
|
Child Behavior | 1 | 2001 | 865 | 0.030 |
Why?
|
Air Pollution, Indoor | 1 | 2003 | 931 | 0.030 |
Why?
|
Morbidity | 1 | 2001 | 1749 | 0.030 |
Why?
|
Information Dissemination | 1 | 2004 | 1142 | 0.030 |
Why?
|
Blotting, Western | 1 | 2003 | 5020 | 0.030 |
Why?
|
Frail Elderly | 1 | 2001 | 785 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2002 | 2424 | 0.030 |
Why?
|
Polymerase Chain Reaction | 2 | 2001 | 6069 | 0.030 |
Why?
|
Attitude to Health | 1 | 2004 | 2020 | 0.030 |
Why?
|
Community Health Planning | 1 | 2015 | 164 | 0.030 |
Why?
|
Liver Diseases | 1 | 2003 | 1303 | 0.030 |
Why?
|
Software | 1 | 2008 | 4462 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2008 | 20124 | 0.030 |
Why?
|
Peritonitis | 1 | 1996 | 369 | 0.030 |
Why?
|
Rural Population | 1 | 2005 | 2317 | 0.030 |
Why?
|
Information Systems | 1 | 1976 | 400 | 0.030 |
Why?
|
Financing, Organized | 1 | 2015 | 201 | 0.030 |
Why?
|
Medicaid | 2 | 2005 | 2833 | 0.030 |
Why?
|
Investments | 1 | 2015 | 148 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2003 | 2844 | 0.030 |
Why?
|
Gynecology | 1 | 1999 | 535 | 0.030 |
Why?
|
Chi-Square Distribution | 2 | 2014 | 3432 | 0.030 |
Why?
|
Body Composition | 1 | 2002 | 2439 | 0.030 |
Why?
|
Genomics | 1 | 2009 | 5929 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2003 | 1959 | 0.030 |
Why?
|
Databases, Factual | 1 | 2008 | 8067 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2005 | 5125 | 0.030 |
Why?
|
Obstetrics | 1 | 1999 | 680 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2001 | 2186 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1543 | 0.020 |
Why?
|
Financing, Government | 1 | 2015 | 473 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2011 | 6942 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2002 | 3312 | 0.020 |
Why?
|
Comparative Effectiveness Research | 1 | 2016 | 714 | 0.020 |
Why?
|
Goals | 1 | 2015 | 719 | 0.020 |
Why?
|
Alkynes | 1 | 2011 | 326 | 0.020 |
Why?
|
Prognosis | 2 | 2016 | 29922 | 0.020 |
Why?
|
Seat Belts | 2 | 2001 | 60 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 4058 | 0.020 |
Why?
|
Population | 1 | 2009 | 140 | 0.020 |
Why?
|
Cyclopropanes | 1 | 2011 | 437 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2016 | 746 | 0.020 |
Why?
|
Spain | 1 | 2010 | 483 | 0.020 |
Why?
|
Vaccines | 1 | 2017 | 841 | 0.020 |
Why?
|
Cytological Techniques | 1 | 2010 | 220 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2007 | 39193 | 0.020 |
Why?
|
Survival Rate | 1 | 2002 | 12795 | 0.020 |
Why?
|
Recurrence | 1 | 2001 | 8501 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2001 | 15398 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2002 | 3230 | 0.020 |
Why?
|
Cross Infection | 1 | 1996 | 1427 | 0.020 |
Why?
|
American Cancer Society | 1 | 2007 | 69 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2002 | 4353 | 0.020 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 2006 | 19 | 0.020 |
Why?
|
Drug Resistance, Microbial | 2 | 2001 | 833 | 0.020 |
Why?
|
Isoproterenol | 1 | 2006 | 398 | 0.020 |
Why?
|
Mycobacterium Infections | 1 | 2006 | 123 | 0.020 |
Why?
|
Wounds and Injuries | 1 | 1998 | 2511 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2001 | 7478 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15880 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 430 | 0.010 |
Why?
|
Georgia | 1 | 2005 | 186 | 0.010 |
Why?
|
Probability | 1 | 2010 | 2475 | 0.010 |
Why?
|
Regression Analysis | 2 | 2006 | 6322 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2006 | 345 | 0.010 |
Why?
|
Social Justice | 1 | 2009 | 485 | 0.010 |
Why?
|
Asthma | 1 | 2003 | 6270 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 618 | 0.010 |
Why?
|
Psychiatry | 1 | 1976 | 1714 | 0.010 |
Why?
|
Blood Donors | 1 | 2006 | 342 | 0.010 |
Why?
|
Tachycardia | 1 | 2006 | 594 | 0.010 |
Why?
|
Health Promotion | 1 | 2015 | 2208 | 0.010 |
Why?
|
Hospitalization | 2 | 2001 | 10808 | 0.010 |
Why?
|
Haiti | 1 | 2005 | 553 | 0.010 |
Why?
|
Mycoses | 1 | 2006 | 389 | 0.010 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2006 | 511 | 0.010 |
Why?
|
Occupations | 1 | 2005 | 516 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2007 | 1776 | 0.010 |
Why?
|
World Health Organization | 1 | 2008 | 1328 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2006 | 12056 | 0.010 |
Why?
|
Algorithms | 2 | 2002 | 14071 | 0.010 |
Why?
|
Retrospective Studies | 4 | 2006 | 81514 | 0.010 |
Why?
|
Pediatric Assistants | 1 | 2001 | 8 | 0.010 |
Why?
|
Gestational Age | 1 | 2010 | 3609 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2009 | 1078 | 0.010 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2006 | 881 | 0.010 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2006 | 769 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1820 | 0.010 |
Why?
|
Natural Childbirth | 1 | 2000 | 15 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2263 | 0.010 |
Why?
|
Cefazolin | 1 | 2001 | 94 | 0.010 |
Why?
|
Infant, Premature | 1 | 2010 | 2122 | 0.010 |
Why?
|
Vancomycin Resistance | 1 | 2001 | 125 | 0.010 |
Why?
|
Methicillin Resistance | 1 | 2001 | 198 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1731 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2016 | 4533 | 0.010 |
Why?
|
Uterine Cervical Diseases | 1 | 2000 | 75 | 0.010 |
Why?
|
Cephalosporins | 1 | 2001 | 200 | 0.010 |
Why?
|
Immunocompromised Host | 1 | 2006 | 866 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2009 | 6203 | 0.010 |
Why?
|
Florida | 1 | 2001 | 416 | 0.010 |
Why?
|
Patient Simulation | 1 | 2002 | 301 | 0.010 |
Why?
|
Sexual Partners | 1 | 2005 | 804 | 0.010 |
Why?
|
Seasons | 1 | 2006 | 1524 | 0.010 |
Why?
|
Drug Resistance | 1 | 2006 | 1591 | 0.010 |
Why?
|
Early Diagnosis | 1 | 2005 | 1187 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2001 | 18071 | 0.010 |
Why?
|
Exercise | 1 | 2016 | 5937 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2006 | 1297 | 0.010 |
Why?
|
Pneumonia, Viral | 1 | 1997 | 3223 | 0.010 |
Why?
|
New York | 1 | 2001 | 880 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2002 | 541 | 0.010 |
Why?
|
Organizational Policy | 1 | 2001 | 434 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2004 | 1628 | 0.010 |
Why?
|
Premature Birth | 1 | 2010 | 1829 | 0.010 |
Why?
|
Eligibility Determination | 1 | 2002 | 423 | 0.010 |
Why?
|
State Government | 1 | 2001 | 388 | 0.010 |
Why?
|
Bacterial Infections | 1 | 2006 | 1387 | 0.010 |
Why?
|
Diet | 1 | 2016 | 8086 | 0.010 |
Why?
|
Length of Stay | 2 | 2005 | 6485 | 0.010 |
Why?
|
Efficiency, Organizational | 1 | 2002 | 697 | 0.010 |
Why?
|
Self Efficacy | 1 | 2002 | 642 | 0.010 |
Why?
|
Saskatchewan | 1 | 1976 | 8 | 0.010 |
Why?
|
Malaria | 1 | 2006 | 1246 | 0.010 |
Why?
|
Guidelines as Topic | 1 | 2002 | 1394 | 0.010 |
Why?
|
Connecticut | 1 | 1996 | 365 | 0.010 |
Why?
|
Immunization | 1 | 2000 | 1219 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2844 | 0.010 |
Why?
|
Enterococcus | 1 | 1996 | 157 | 0.010 |
Why?
|
Treatment Failure | 1 | 2001 | 2652 | 0.010 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1997 | 755 | 0.010 |
Why?
|
Physician's Role | 1 | 2001 | 927 | 0.010 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 1996 | 239 | 0.010 |
Why?
|
Heart Rate | 1 | 2006 | 4204 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2002 | 2739 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2009 | 4300 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 1996 | 339 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2006 | 8529 | 0.010 |
Why?
|
Craniocerebral Trauma | 1 | 1998 | 494 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2001 | 1424 | 0.010 |
Why?
|
Peripheral Vascular Diseases | 1 | 1996 | 516 | 0.010 |
Why?
|
Tuberculosis | 1 | 2006 | 2012 | 0.010 |
Why?
|
Serum Albumin | 1 | 1996 | 675 | 0.010 |
Why?
|
Community Mental Health Services | 1 | 1976 | 381 | 0.010 |
Why?
|
Bronchi | 1 | 1997 | 843 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2005 | 26318 | 0.010 |
Why?
|
Europe | 1 | 1999 | 3423 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9373 | 0.010 |
Why?
|
Pilot Projects | 1 | 2005 | 8733 | 0.010 |
Why?
|
Chronic Disease | 1 | 2006 | 9347 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2003 | 2412 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2005 | 7838 | 0.010 |
Why?
|
Insurance Coverage | 1 | 2002 | 1944 | 0.010 |
Why?
|
Equipment Design | 1 | 1998 | 3481 | 0.010 |
Why?
|
Research Design | 1 | 2006 | 6209 | 0.010 |
Why?
|
Patient Admission | 1 | 1996 | 1365 | 0.000 |
Why?
|
Gastrointestinal Diseases | 1 | 1996 | 1203 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2002 | 12509 | 0.000 |
Why?
|
Comorbidity | 1 | 1996 | 10563 | 0.000 |
Why?
|
Prospective Studies | 1 | 2006 | 54802 | 0.000 |
Why?
|
Alzheimer Disease | 1 | 2000 | 8730 | 0.000 |
Why?
|
Diabetes Mellitus | 1 | 1996 | 5891 | 0.000 |
Why?
|